If you've spent any time around the longevity community, you've probably heard about NAD+. It's a coenzyme your cells use for hundreds of jobs, and the levels you carry around aren't fixed for life. They drift downwards as the years stack up. That's the bit researchers find interesting.
What NAD+ actually does
NAD+ (short for nicotinamide adenine dinucleotide) sits at the centre of cellular metabolism. Every cell uses it to convert food into usable energy. Beyond that, two families of enzymes lean on NAD+ heavily: PARPs (which patrol DNA for damage) and sirtuins (often described as "longevity proteins" because of their role in regulating gene expression).
None of that is controversial. Open any biochemistry textbook from the last forty years and NAD+ shows up on the same handful of pages. What is newer, and what's drawing attention, is the idea that the amount of NAD+ inside your cells matters, and that it changes over time.
The decline researchers keep finding
Multiple groups have measured NAD+ levels across age ranges in tissues like skin, muscle, and blood. The pattern is fairly consistent: levels in midlife are noticeably lower than in our twenties, and the slope continues. A 2018 paper by Massudi and colleagues, looking at human skin, found roughly a 50% drop between younger and older adults. Other groups have replicated similar trends in other tissues.
Nobody's claiming NAD+ alone explains why bodies change as they age. Biology rarely lets you pull on one thread that cleanly. But the decline is reproducible, and it lines up with periods when people start noticing the small shifts: slower recovery after a hard week, less of a fizz when the alarm goes off, the kind of changes you can shrug at in your thirties and start to feel by your fifties.
Where NMN fits in
NAD+ doesn't appear out of nowhere. Your body builds it from precursor molecules: vitamin B3 derivatives, mostly. NMN (nicotinamide mononucleotide) is one of those precursors. It's one chemical step away from NAD+, which is part of why researchers picked it up as a candidate for raising NAD+ levels through supplementation.
You do get small amounts of NMN from food. Broccoli, edamame, and avocado all contain it, but in trace quantities, far below the doses used in published trials. That's the case for taking it as a supplement: not because food is failing you, but because the amounts that show up in research aren't realistically reachable through diet alone.
What the human trials look like so far
The published human research on NMN is still relatively young: the first oral NMN trial in humans only ran in 2019. Since then, a handful of small trials have looked at things like blood NAD+ metabolites, muscle function, and insulin sensitivity. The results have generally pointed in promising directions, though the trial sizes are modest and follow-up periods short.
NMN isn't a miracle. It's a precursor molecule that may support NAD+ levels which naturally decline with age, and the early human evidence is encouraging without being definitive. Anyone telling you otherwise is either selling something or hasn't read the papers.
What this means in practice
If you're in your forties or fifties and curious about NMN, here's the plain framing: you're trying a well-studied precursor at a dose that mirrors published research, on the basis that supporting NAD+ levels which decline with age is a reasonable thing to do. There's no cure for ageing. You're paying attention to a piece of cellular biology that researchers think matters, and giving your body a bit of raw material to work with.
Take it with food. Take it consistently. Give it a few weeks before judging anything. And if it's not for you, stop. Cellular wellbeing isn't built on any single capsule. It's the sum of sleep, movement, food, and the small daily decisions that compound over decades. NMN, if you take it, is one small input among many.
